mRNA COVID-19 Vaccines: Science vs. Misinformation
- Jeffery M. Coller1,8,
- Andrew Geall2,
- Roberta Duncan3,
- Clay Alspach4,
- Sean P Ryder5,
- Melissa J Moore6 and
- Fatima P Gebauer7
- 1 Johns Hopkins University;
- 2 Replicate Bioscience;
- 3 Arcturus Therapeutics;
- 4 The Alliance for mRNA Medicines;
- 5 University of Massachusetts Chan Medical School;
- 6 UMass Memorial Medical Center;
- 7 The Barcelona Institute for Science and Technology
- ↵* Corresponding author; email: jmcoller{at}jhmi.edu
Abstract
The rapid development of COVID-19 vaccines as a result of Operation Warp Speed represented an extraordinary triumph of scientific innovation, with multiple vaccine platforms demonstrating remarkable efficacy in preventing severe disease, hospitalization, and death—ultimately saving millions of lives. The United States government, pharmaceutical companies, research institutions, and health agencies collaborated at an unprecedented scale to develop, test, and distribute vaccines, showcasing what coordinated medical innovation can accomplish. Vaccination programs successfully prevented catastrophic outcomes and enabled people to return to normal life during the crisis. COVID-19 vaccines continue to provide critical protection for vulnerable populations today, and the mRNA platforms developed have opened new possibilities for treating cancers and other diseases. Yet despite rigorous regulatory oversight and extensive clinical trial data, these vaccines have faced substantial misinformation campaigns that spread false claims about their safety and design. To address these misrepresentations and resultant public concerns, this document draws on rigorous scientific evidence to comprehensively examine the misconceptions surrounding mRNA technology, explaining how these vaccines work, their proven safety record, and their demonstrated benefits.
Keywords
- Received January 5, 2026.
- Accepted February 16, 2026.
- Published by Cold Spring Harbor Laboratory Press for the RNA Society
This article, published in RNA, is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.










